Suzuken
9987.TTSE PRIMEWholesale Trade
Financials · Standalone
| Fiscal year ended | 2026-03 | 2025-03 | 2024-03 | 2023-03 | 2022-03 | 2021-03 |
|---|---|---|---|---|---|---|
| Revenue | ¥2.30T | ¥2.21T | ¥2.19T | ¥2.12T | ¥2.04Tr | ¥1.93T |
| Operating income | ¥22.7bn | ¥23.9bn | ¥23.6bn | ¥20.3bn | ¥10.4bnr | ¥2.3bn |
| Ordinary income | ¥28.2bn | ¥28.8bn | ¥28.5bn | ¥24.7bn | ¥14.9bn | ¥11.8bn |
| Total assets | ¥1.04T | ¥1.02T | ¥1.13T | ¥1.05T | ¥1.03T | ¥1.00T |
| Net assets / equity | ¥269.2bn | ¥271.6bn | ¥286.6bn | ¥290.8bn | ¥302.5bn | ¥303.2bn |
| EPS (basic) | ¥418.27 | ¥339.09 | ¥259.73 | ¥172.97 | ¥156.55 | ¥67.15 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 4
| Period | Form | Figures |
|---|---|---|
| 2023-04-01 → 2023-12-31 | Quarterly Q3 | 45 figures · EDINET |
| 2023-04-01 → 2023-09-30 | Quarterly Q2 | 69 figures · EDINET |
| 2023-04-01 → 2023-06-30 | Quarterly Q1 | 43 figures · EDINET |
| 2022-04-01 → 2023-03-31 | Annual | 197 figures · EDINET |
23 more reports are still being processed.
Segments · FY ended 2026-03
| Segment | External sales | Profit |
|---|---|---|
| The Community Healthcare And Nursing Care Support Business | ¥93.9bn | ¥1.5bn |
| The Healthcare Product Development Business | ¥11.9bn | ¥830m |
| The Healthcare Related Services Business | ¥24.6bn | ¥1.3bn |
| The Pharmaceutical Distribution Business | ¥2.35T | ¥31.5bn |
| The Specialty Drug Contract Distribution Business | ¥6.8bn | ¥1.2bn |
| Total | ¥2.49T | ¥36.3bn |
Segment names from EDINET member IDs; not mapped to a common taxonomy.